CLINICAL_TRIALS
trial_result
· 2014-12-01
Clinical Trial Update: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS [Phase 2]
Summary
Phase 2 open-label trial of eculizumab in adult patients with plasma therapy-resistant atypical hemolytic uremic syndrome completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Atypical Hemolytic Uremic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2014-12-01